Roche announces two-year data confirming Vabysmo improves neovascular age-related macular degeneration

Optical Coherence Tomography (OTC) tests also showed that extending the dosing schedule for Vabysmo did not compromise disease control when compared with Eylea.

Bayer's drop of the future

Even then, the portents were clear: educated patients with less deference to professionals, crude wearables like step counters and rising OTC sales of old technologies, like blood pressure cuffs, that were

Takeda to sell Japan consumer health unit for $2.3bn

The Japanese pharma also entered an agreement with Stada last October to divest a portfolio of select OTC drugs for a total value of $660m. ... The Stada deal includes OTC vitamins and food supplements, and select products in the cardiovascular, diabetes,

Takeda divests over-the-counter and prescription drugs to Stada for $660m

It includes OTC vitamins and food supplements, and select products in the cardiovascular, diabetes, general medicine and respiratory therapeutic areas. ... In October, Takeda announced that it had agreed to divest a number of OTC and prescription

Takeda offloads select portfolio to Acino ahead of Shire takeover

Hopes to reduce debt before acquistion completion. Japanese pharma Takeda has agreed to divest a number of over-the-counter (OTC) and prescription medicines in emerging markets to Acino for $200m.

Healthcare creatives need to be more like Bryson

Isn’t it all a bit samey? Health is a spectrum: from illness to wellness, prescription to OTC.

Cortellis Drugs to Watch in 2020 report

The drug entered into a market largely dominated by OTC products and triptans.

It’s not the end of the world, is it?

We might see an industry much more like OTC, where specialised channels hold much of the power and pharmaceutical companies have to fight for brand recognition and ‘ownership’ of the customer.

Drug R&D

Legal and regulatory affairs

Ann Barbier joins Translate Bio as its chief medical officer

She said: “With near-term clinical programmes in cystic fibrosis and OTC deficiency, Translate Bio is approaching a critical and exciting time.

Spink appoints account manager Zoe Baptie

Baptie joins Spink from Sparkle PR where she worked as Account Manager on their health team across OTC health and beauty products.

Virgo Consumer Health & Wellbeing hires Kirsty McKinnon

Med comms agency strengthens senior team with new personal care sector lead

Novartis announces departures of three execs

George Gunn, head of Novartis animal health; Brian McNamara, head of Novartis OTC; and Andrin Oswald, head of Novartis vaccines, will all leave the Switzerland-based company once the transactions are ... As for McNamara – a ten-year veteran of Novartis

Gopa Mitra retires from PAGB

self-care using OTC products part of UK health policy. ... PAGB Chief Executive, Matthew Speers said: “Gopa has made an outstanding contribution to PAGB and the OTC industry as a whole.

Maloff Mosquito

Therapy area: OTC Products.

Eoin McAtamney announced as Managing Director of Ashfield Ireland

Prior to this, Eoin was Business Unit Director (UK and Ireland) with Pharmed Group, where he managed the Pharmaceutical &OTC division in Ireland and led the successful entry and development of

Four appoints Matt de Gruchy as chief executive of health unit

The unit’s client roster includes 18 of the world’s top 20 pharma companies, OTC companies and public sector organisations.

Flexible working success

The unit’s client roster includes 18 of the world’s top 20 pharma companies, OTC companies and public sector organisations.

Maxwellia works with 11 London for social promotion of first ever OTC contraceptive pill

We’re excited to announce that we are now working with pioneering British pharma company Maxwellia to help launch Lovima, a contraceptive pill to be available in pharmacies without the need for a doctor’s prescription – for the first time in